HFNC vs standard oxygen therapy
In‐hospital mortality (up to 90 days; included studies reported in‐hospital mortality, and mortality up to 28 days and up to ICU discharge) · adults in the ICU, requiring respiratory support
HFNC showed no clear difference in in‐hospital mortality (up to 90 days; included studies reported… compared with standard oxygen therapy (moderate certainty).
1 finding from 1 review
- High‐flow nasal cannulae for respiratory support in adult intensive care patients 2021 · Cochrane Headline outcomes onlyRR 0.96 [0.82, 1.11]11 studies · 2673 participantsModerate